SEC EDGAR filings, ownership reports, and insider transactions for BCIP Life Sciences Associates, LP.
Recent SEC filings for BCIP Life Sciences Associates, LP including 144, 4, 3 and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 144 | Open 144 document | View SEC filing for 144 | 02 Dec 2025 | |||
| 144 | Open 144 document | View SEC filing for 144 | 24 Jul 2025 | |||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 21 Feb 2025 | 19 Feb 2025 | 001-38360 |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 17 Dec 2024 | 13 Dec 2024 | 001-41562 |
| 144 | Open 144 document | View SEC filing for 144 | 11 Dec 2024 | |||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 12 Jan 2024 | 11 Jan 2024 | 001-38360 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 29 Dec 2023 | 29 Dec 2023 | 001-41562 |
| 144 | Open 144 document | View SEC filing for 144 | 24 Oct 2023 | |||
| 144 | Open 144 document | View SEC filing for 144 | 10 Oct 2023 | |||
| 144 | Open 144 document | View SEC filing for 144 | 08 Aug 2023 | |||
| 144 | Open 144 document | View SEC filing for 144 | 14 Jun 2023 | |||
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 30 May 2023 | 25 May 2023 | 001-39402 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 30 May 2023 | 25 May 2023 | 001-39402 |
| 144 | Open 144 document | View SEC filing for 144 | 18 May 2023 | |||
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 05 Dec 2022 | 02 Dec 2022 | 001-38360 |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Nov 2022 | 30 Sep 2022 | 028-21927 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 Aug 2022 | 30 Jun 2022 | 028-21927 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 16 May 2022 | 31 Mar 2022 | 028-21927 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Feb 2022 | 31 Dec 2021 | 028-21927 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Dec 2021 | 08 Dec 2021 | 001-40925 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 05 Nov 2021 | 26 Oct 2021 | 001-40925 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 21 Jul 2021 | 19 Jul 2021 | 001-40592 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 14 Jul 2021 | 14 Jul 2021 | 001-40592 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 27 Oct 2020 | 26 Oct 2020 | 001-38535 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 28 Jul 2020 | 28 Jul 2020 | 001-39402 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 23 Jul 2020 | 23 Jul 2020 | 001-39402 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Feb 2020 | 04 Feb 2020 | 001-39186 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 30 Jan 2020 | 30 Jan 2020 | 001-39186 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 16 Jan 2020 | 14 Jan 2020 | 001-38535 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 21 Nov 2019 | 19 Nov 2019 | 001-36281 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 31 May 2019 | 29 May 2019 | 001-36281 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 26 Jul 2018 | 24 Jul 2018 | 001-38596 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 19 Jul 2018 | 19 Jul 2018 | 001-38596 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Dec 2017 | 15 Dec 2017 | 001-36576 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Dec 2017 | 18 Dec 2017 | 001-36281 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 28 Sep 2017 | 19 Sep 2017 | 001-36576 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 13 Apr 2017 | 11 Apr 2017 | 001-36281 |
BCIP Life Sciences Associates, LP files with the SEC under CIK 0001702921. This page aggregates EDGAR filings and related ownership activity.